ArticleThe journal of medicine access
COVID-19 pandemic effects on seminal fluid analysis parameters: A prospective cohort study.
Article in The journal of medicine access. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- COVID-19 pandemic effects on seminal fluid analysis parameters: Comment.The journal of medicine accessArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To investigate the effects of the Coronavirus disease 2019 (COVID-19) virus on seminal fluid analysis (SFA) parameters in patients who have had the infection. Background: COVID-19 is caused by severe acute respiratory syndrome coronavirus 2 and has had a significant global impact. Recent studies suggest a potential relationship between COVID-19 and male reproductive health, particularly in its effects on semen quality. Methods: A prospective cohort study was conducted, and the trial had 50 participants outset (6 participants were lost to follow-up later, and the final analysis involved 44 participants). The study was conducted at the Baghdad Medical City Complex, and it lasted from August 2020 to August 2022. Patients who had received any COVID-19 vaccination were excluded. Results: In the present study, 44 male participants were included in this study, their mean age is 31.8 ± 5.1 years ranging from 22 to 42 years, their mean body mass index is 24.7 ± 3.4 kg/m Conclusion: COVID-19 infection has a negative effect on SFA parameters during the first 3 months of post-viral infection. Parameters of SFA recovered to levels comparable to baseline SFA between 3 and 6 months after viral infection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.